批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/02/15 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/10/19 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/10/19 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/10/12 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/11/01 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/11/10 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/09/23 |
SUPPL-4(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2014/05/21 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/04/18 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/10/29 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:ESTRADIOL 剂型/给药途径:FILM, EXTENDED RELEASE;TRANSDERMAL 规格:0.0375MG/24HR 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
203752 |
001 |
NDA |
MINIVELLE |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.0375MG/24HR |
Prescription |
Yes |
No |
AB3 |
2012/10/29
|
NOVEN |
206685 |
002 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.0375MG/24HR |
Prescription |
No |
No |
AB3 |
2018/08/15
|
MYLAN TECHNOLOGIES |
211396 |
002 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.0375MG/24HR |
Prescription |
No |
No |
AB3 |
2020/09/28
|
AMNEAL |
活性成分:ESTRADIOL 剂型/给药途径:FILM, EXTENDED RELEASE;TRANSDERMAL 规格:0.075MG/24HR 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
203752 |
002 |
NDA |
MINIVELLE |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.075MG/24HR |
Prescription |
Yes |
No |
AB3 |
2012/10/29
|
NOVEN |
206685 |
004 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.075MG/24HR |
Prescription |
No |
No |
AB3 |
2018/08/15
|
MYLAN TECHNOLOGIES |
211396 |
004 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.075MG/24HR |
Prescription |
No |
No |
AB3 |
2020/09/28
|
AMNEAL |
活性成分:ESTRADIOL 剂型/给药途径:FILM, EXTENDED RELEASE;TRANSDERMAL 规格:0.05MG/24HR 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
203752 |
003 |
NDA |
MINIVELLE |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.05MG/24HR |
Prescription |
Yes |
No |
AB3 |
2012/10/29
|
NOVEN |
206685 |
003 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.05MG/24HR |
Prescription |
No |
No |
AB3 |
2018/08/15
|
MYLAN TECHNOLOGIES |
211396 |
003 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.05MG/24HR |
Prescription |
No |
No |
AB3 |
2020/09/28
|
AMNEAL |
活性成分:ESTRADIOL 剂型/给药途径:FILM, EXTENDED RELEASE;TRANSDERMAL 规格:0.1MG/24HR 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
203752 |
004 |
NDA |
MINIVELLE |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.1MG/24HR |
Prescription |
Yes |
Yes |
AB3 |
2012/10/29
|
NOVEN |
206685 |
005 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.1MG/24HR |
Prescription |
No |
No |
AB3 |
2018/08/15
|
MYLAN TECHNOLOGIES |
211396 |
005 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.1MG/24HR |
Prescription |
No |
No |
AB3 |
2020/09/28
|
AMNEAL |
活性成分:ESTRADIOL 剂型/给药途径:FILM, EXTENDED RELEASE;TRANSDERMAL 规格:0.025MG/24HR 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
203752 |
005 |
NDA |
MINIVELLE |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.025MG/24HR |
Prescription |
Yes |
No |
AB3 |
2014/09/23
|
NOVEN |
206685 |
001 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.025MG/24HR |
Prescription |
No |
No |
AB3 |
2018/08/15
|
MYLAN TECHNOLOGIES |
211396 |
001 |
ANDA |
ESTRADIOL |
ESTRADIOL |
FILM, EXTENDED RELEASE;TRANSDERMAL |
0.025MG/24HR |
Prescription |
No |
No |
AB3 |
2020/09/28
|
AMNEAL |